Meningitis c vaccine

Even if you received meningococcal vaccines , you could still get meningococcal disease. Teens may also get a MenB vaccine , preferably at through years old. Meningococcal Vaccination. Vaccines can help prevent meningococcal disease, which is any type of illness caused by Neisseria meningitidis bacteria. Two meningococcal vaccines (MenACWY and MenB) provide protection against the serogroups that cause most meningococcal disease in the United States.

The meningococcal conjugate vaccine protects against four types of meningococcal bacteria (called types A, C, W, and Y).

It is recommended for all kids. Two meningitis vaccines protects against four types of meningococcal disease. An additional type of vaccine protects against serotype B, which also causes meningitis.

Different versions are effective against some or all of the following types of meningococcus : A, B, C , W-13 and Y. The vaccines are between and 1 effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin. Vaccines that protect against some common causes of life-threatening bacterial meningitis and septicaemia are routinely available in many parts of the world.

The meningitis B vaccine is a new vaccine that offers protection against meningococcal group B bacteria , which are a common cause of meningitis in young children in the UK.

A different meningococcal vaccine is available that can help protect against serogroup B. When should you get a meningococcal vaccine? How is Menactra vaccine administered? What are the dangers of meningitis? Are Menveo and Menactra interchangeable?

Find Your Nearest Walgreens To Get Yours Today! Since protection wanes, CDC recommends a booster dose at age years. The booster dose provides protection during the ages when adolescents are at highest risk of meningococcal disease.

What is the meningitis ( meningococcal) vaccine ? This vaccine protects about percent of people who get it. In addition, all teens may be vaccinated with a MenB vaccine , preferably at age through 18. Multiple doses are required and the same brand must be used for all doses. A new hyper-invasive strain of meningococcal meningitis serogroup C is circulating at the same time that an acute shortage of meningitis C-containing vaccine threatens to severely limit the region’s ability to minimize the number of persons affected.

The new serogroup C strain now represents the major risk of meningitis outbreaks in the region. Call your health care provider to make an appointment. Read the patient information leaflet for Nimenrix (PDF, 491kb).

Skip directly to site content Skip directly to page options Skip directly to A-Z link Centers for Disease Control and Prevention. The MenACWY vaccine is called Nimenrix.

Another CDC-recommended option is the serogroup B meningoccal (MenB). Although not all of these side effects may occur, if they do occur they may need medical attention. Infants may receive Men- C - C vaccine beginning at months of age, depending on the provincial and territorial schedule and the incidence of meningococcal serogroup C disease in their jurisdiction. This can be used to protect babies under the age of months.

Infants who are less than months of age need three doses to be protected. Children over months of age and adults need one dose to be protected. BEXSERO is approved for use in individuals through years of age.